Thursday, August 20, 2020

Update on COVID-19 vaccine

Astrazeneca is currently working on a vaccine against COVID-19 and has reported on early findings of tests carried out in human volunteers.

Published in The Lancet of 20th July, the paper gives details of results of a study carried out on 1077 volunteers who were either given the COVID-19 or a meningitis vaccine.

The researchers found that the COVID-19 vaccine was generally well tolerated with causation of mild side effects which were easily controlled by paracetamol. 

The vaccine gave promising results in that it elicited a response from the subjects' immune system of antibody and cellular type.

Currently there are 160 vaccines undergoing research in a global effort to combat the devastating coronavirus pandemic.



No comments: